A double-blind controlled clinical trial to evaluate the effects of nasal therapy with Vrihatajivakadya oil on different viscosities in patients with migraine
Open Access
- 1 March 2023
- journal article
- research article
- Published by Elsevier BV in Journal of Ayurveda and Integrative Medicine
- Vol. 14 (2), 100662
- https://doi.org/10.1016/j.jaim.2022.100662
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health StudiesHeadache: The Journal of Head and Face Pain, 2018
- Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of ActionNeurotherapeutics, 2017
- Formulation Development and Evaluation of Lyophilized Nasal Inserts for Migraine TreatmentRecent Advances in Drug Delivery and Formulation, 2017
- A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.The Journal of Headache and Pain, 2017
- Prevalence, burden, and risk factors of migraine: A community-based study from Eastern IndiaNeurology India, 2017
- AVP‐825 Breath‐Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple AttacksHeadache: The Journal of Head and Face Pain, 2015
- Migraine: Multiple Processes, Complex PathophysiologyJournal of Neuroscience, 2015
- A Randomized, Double‐Blind, Placebo‐Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP‐825) in the Treatment of Acute Migraine (The TARGET Study)Headache: The Journal of Head and Face Pain, 2014
- A comparative review study of Sneha Kalpana (Paka) vis-a-vis liposomeAyu, 2011
- Speed of Onset and Efficacy of Zolmitriptan Nasal Spray in the Acute Treatment of MigraineCNS Drugs, 2003